NCT00740805 2026-03-18Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Active not recruiting81 enrolled